← Leaderboards
Daniel A Erlanson
Sunesis Pharmaceuticals, Inc.
$750,000
Attributed
$750,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$750,000 · 1
By mechanism
R44$750,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Sunesis Pharmaceuticals, Inc.
Same institution · by research overlap
- Christopher D Thanos$137,733
- John C Prescott$850,000
- Robert S Mc Dowell$500,000
- Justin M Scheer$41,744
- W Michael Flanagan$100,000
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionDrug Discovery /IsolationDrug Screening /EvaluationLaboratory MouseMitogen Activated Protein Kinase